Bruker Corporation

Healthcare · Medical Devices

61.60$ +0.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Bruker Corporation (BRKR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 6,241 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BRKR
Line item	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	64	67	185	189	203	351	372	361	433	553	1,116	1,172	1,550	1,711	1,856	1,988	1,865	1,731	1,813	1,949	2,129	2,772	3,049	3,650	3,612	4,250	5,807	6,241
Current Assets	–	42	147	139	145	251	271	266	295	396	821	874	1,051	1,194	1,310	1,432	1,366	1,232	1,273	1,359	1,304	1,796	1,925	2,472	2,113	2,164	2,053	2,213
Cash	–	2.4	22	8.4	32	63	33	53	52	73	166	207	230	246	311	439	320	267	342	325	322	678	682	1,068	646	488	183	299
Cash & Short-Term Investments	–	2.4	95	70	47	77	78	100	52	73	168	207	230	246	311	439	498	468	500	439	322	685	732	1,168	646	488	183	299
Receivables	–	12	12	16	27	55	67	54	89	122	172	184	233	283	289	308	293	235	244	319	357	362	335	417	595	622	701	736
Inventory	–	25	37	48	68	110	108	96	135	171	425	423	511	576	612	590	477	422	440	486	510	577	692	710	800	968	1,068	1,095
Property, Plant & Equipment	–	–	26	37	53	81	85	72	90	103	221	223	234	249	284	300	250	231	239	267	271	306	396	406	487	–	–	–
Goodwill	–	–	–	–	–	11	11	18	40	41	46	48	98	100	116	127	128	131	131	170	276	293	320	340	458	583	1,507	1,548
Intangible Assets	–	0.4	2.3	1.6	3.4	13	1.4	1.5	5.6	4.1	6.0	4.9	136	136	117	106	84	268	70	323	219	233	229	212	271	331	913	900
Total Liabilities	54	57	60	62	77	148	154	153	241	294	804	753	1,022	1,086	1,147	1,138	1,093	998	1,120	1,215	1,224	1,833	2,075	2,565	2,480	2,837	3,992	3,731
Current Liabilities	–	29	36	39	58	109	111	112	195	253	520	539	832	756	682	649	583	555	526	525	598	646	792	939	914	1,202	1,281	1,279
Short-Term Debt	–	2.5	–	3.9	18	19	-13	9.6	-22	14	41	22	214	84	1.3	0.7	0.8	0.7	20	416	19	21	24	130	35	145	65	52
Accounts Payable	–	6.7	7.6	9.9	21	23	23	17	23	33	43	50	64	72	70	75	76	72	86	91	105	118	135	147	178	203	234	216
Long-Term Debt	–	–	12	11	8.0	26	28	21	23	6.4	183	116	87	219	336	354	354	265	392	416	323	813	842	1,222	1,201	1,160	2,062	1,853
Shareholders' Equity	10	10	124	128	126	202	217	208	191	259	312	419	527	625	707	850	772	733	693	734	905	907	961	1,071	1,114	1,377	1,781	2,457
Retained Earnings	–	6.4	8.7	12	6.1	-14	-22	-19	17	48	173	254	349	442	519	599	656	757	885	942	1,103	1,275	1,407	1,660	1,926	2,324	2,407	2,362
Shares Outstanding	46	46	56	54	53	103	96	101	103	164	166	165	166	167	167	169	170	169	162	159	157	157	155	153	149	147	150	152

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings